Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1993
10/14/1993CA2117884A1 Non-infectious hiv particles and uses therefor
10/14/1993CA2110283A1 Physiologically active protein and hemotopoietic stem cell growth agent
10/13/1993EP0565484A2 HIV-protease inhibiting morpholin- and thiomorpholin-4-ylamides
10/13/1993EP0565370A1 Serotonin receptor protein and related DNA compounds
10/13/1993EP0565208A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment
10/13/1993EP0565172A1 Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity
10/13/1993EP0565164A1 Synthetic polypeptides as inhibitors of HIV-1
10/13/1993EP0565148A2 Intermediates for preparation of H-Arg-X-Y-Z-Tyr-R
10/13/1993EP0564801A1 Analysis of host cell shut-off
10/13/1993EP0564689A1 Recombinant live vaccines against Gram-negative enteric pathogens
10/13/1993EP0564592A1 Liver enriched transcription factor
10/13/1993EP0564587A1 Solution phase process for synthesis of peptide
10/13/1993EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters
10/13/1993EP0564533A1 Modified penta- and hexapeptide anaphylatoxin receptor ligands
10/13/1993EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus
10/13/1993EP0564531A1 Enrichment method for variant proteins with altered binding properties
10/13/1993EP0564513A1 TAPETUM-SPECIFIC PROMOTERS FROM $i(BRASSICACEAE) SPP
10/13/1993EP0564502A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing
10/13/1993EP0564495A1 Tissue factor based prothrombin time reagent
10/13/1993EP0564477A1 Fragments of the env protein of the feline immunodeficiency virus, antibodies and their applications in diagnosis
10/13/1993EP0564460A1 An augmented western blot format and immunoassay for detection of viral antibodies
10/13/1993EP0540687A4 Antibody-mediated cofactor-driven reactions
10/12/1993US5252725 α-1-antichymotrypsin, analogues and methods of production
10/12/1993US5252719 Process for preparing protein-oriented membrane
10/12/1993US5252718 Fibroblast growth factor antagonists
10/12/1993US5252717 Marek's disease herpesvirus DNA segments encoding glycoproteins, gD, gI and gE
10/12/1993US5252716 Marek's disease herpesvirus DNA segments encoding glycoproteins, gD, gI and gE
10/12/1993US5252715 Process for the preparation of a pasteurized and iron-free human transferrin and the use thereof
10/12/1993US5252713 Polymeric carriers for non-covalent drug conjugation
10/12/1993US5252711 Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
10/12/1993US5252710 Selective chromatographic separation of Factor VIII from von Willebrand factor; desorption, purification
10/12/1993US5252709 Adjustment of ph of buffer
10/12/1993US5252708 Preparation process for a protein containing at least one intramolecular disulphide bridge by oxidation, at a pH of less than 5.0 of corresponding reduced recombinant protein
10/12/1993US5252706 Oligopeptides with protecting groups, a straight-chain or branched alkyl propyl ether; nonleakage
10/12/1993US5252705 Peptide derivatives
10/12/1993US5252556 Genetic engineered polypeptide; aids diagnosis
10/12/1993US5252482 Precursor of a C-terminal amidated calcitonin
10/12/1993US5252479 Safe vector for gene therapy
10/12/1993US5252475 Methods and vectors for selectively cloning exons
10/12/1993US5252466 Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them
10/12/1993US5252328 Veterinary medicine
10/12/1993US5252296 Method and apparatus for biopolymer synthesis
10/12/1993US5252289 Water soluble 1,2-dithio-3-thiones
10/12/1993US5252216 Using combination chromatography
10/12/1993CA1323139C Method of producing substantially pure albumin
10/11/1993CA2093575A1 Human antithrombin iii mutant
10/10/1993CA2093753A1 Hexapaptide
10/10/1993CA2093506A1 Serotonin receptor protein and related dna compounds
10/08/1993CA2093495A1 Angiotensin ii type-1 receptor and its production
10/07/1993DE4222407C1 Modulartiges Promotor-Konstrukt A modular promoter construct
10/06/1993EP0563797A1 Pyridinium derivatives
10/06/1993EP0563714A2 TNF-Muteins
10/06/1993EP0563627A2 Anti-tumor method and anti-tumor agent
10/06/1993EP0563527A1 Process for the detection of insertion elements or transposons
10/06/1993EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
10/06/1993EP0563385A1 Thrombolytic peptide, production thereof and thrombolytic agent
10/06/1993EP0563383A1 (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity
10/06/1993EP0563329A1 Angiogenic peptides
10/06/1993EP0563323A1 Hiv reverse transcriptase vaccine
10/06/1993EP0563311A1 Improved vaccines
10/06/1993EP0563307A1 Medicaments for the treatment of papillomavirus diseases
10/06/1993EP0563304A1 Neuronal cholinergic differentiation factor
10/06/1993EP0563302A1 Method and apparatus for granulation
10/06/1993EP0563296A1 Optimization of binding proteins
10/06/1993EP0563288A1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
10/06/1993EP0563278A1 Control of gene expression by ionizing radiation
10/06/1993EP0563244A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
10/06/1993EP0563240A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
10/06/1993EP0563239A1 A truncated interleukin-1 receptor gene for the treatment of arthritis
10/06/1993EP0563222A1 Biologically active bactericidal/permeability-increasing protein fragments
10/06/1993EP0563212A1 Synthetic immunoactive peptides having immunomodulating and therapeutic activities
10/06/1993EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS
10/06/1993EP0563175A1 A method of constructing synthetic leader sequences
10/06/1993EP0563172A1 Synthetic bioadhesive polypeptide
10/06/1993EP0563093A1 A composition used as a therapeutic agent against chronic viral hepatic diseases
10/06/1993EP0563091A1 Vaccines based on hepatitis b surface antigen
10/06/1993EP0563089A1 Serotonine receptor of class 1: the 5-ht 1x? receptors
10/06/1993EP0556345A4 Retroviral vectors useful for gene therapy
10/06/1993EP0429497B1 Cocumber mosaic virus coat protein gene
10/06/1993EP0379516B1 Hyper-immune globulin against hiv
10/06/1993EP0356481B1 Purified hemoglobin solutions and method for making same
10/06/1993EP0314749B1 Haemoglobin complexes
10/06/1993CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4
10/05/1993US5250665 Specifically β-β cross-linked hemoglobins and method of preparation
10/05/1993US5250663 Preparing essentially monomeric normal human serum albumin
10/05/1993US5250662 Precipitation of contaminants in acid solution; binding soluble contaminants to anion-exchange resin; pH adjustment
10/05/1993US5250613 Solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor
10/05/1993US5250516 Forming protective layer of thermoelastic polypeptide
10/05/1993US5250515 Method for improving the efficacy of insect toxins
10/05/1993US5250431 Having alteration or deletion in binding site, for reduced binding capability
10/05/1993US5250421 Culturing mammalian cells transfected with DNA expression vector coding in serum free medium containing phospholipid
10/05/1993US5250414 Diagnostic methods using neurite growth regulatory factors
10/05/1993US5250411 Nucleic acid probes specific for Plasmodium vivax and methods of using the same
10/05/1993US5250302 A DNA sequence encoding a polypeptide which together with a matrix induces endochondral bone formation in mammals
10/05/1993US5250297 Medical diagnosis, anticarcinogenic agents
10/05/1993US5250295 Natural killer cell enhancing factor
10/05/1993CA1322735C Microorganism having low acetate forming capability, and process for production of useful substrate using same
10/05/1993CA1322731C Gene for a-type inclusion body of poxvirus
10/05/1993CA1322714C Wound healing and bone regeneration
10/05/1993CA1322713C Compositions and methods for modulating the effect of tnf and il-1
1 ... 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 ... 2916